Denisse Castro-Eguiluz

Dr. Denisse Castro-Eguiluz

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Revista de Investigación Clínica
Verified
Journal Article
Open access
LCLILIA CASTILLO-MARTINEZ
LILIA CASTILLO-MARTINEZ
DCDenisse Castro-Eguiluz
Denisse Castro-Eguiluz
ECErika Thalia Copca-Mendoza
Erika Thalia Copca-Mendoza
DPDana Aline Pérez-Camargo
Dana Aline Pérez-Camargo
CRCarlos Alberto Reyes-Torres
Carlos Alberto Reyes-Torres
MMMaria del Pilar Milke-García
Maria del Pilar Milke-García
Malnutrition and muscle wasting are common features of cancer cachexia that may interfere with the patient's response to cancer treatment, survival, and quality of life. An accurate nutritional screening at the time of diagnosis and throughout the patient's treatment fosters better control of the disease. Several screening tools have proven to be useful for this purpose. Nevertheless, nutritional evaluation is not a routine practice in this clinical setting and procedures must be standardized. Nutritional risk screening (NRS), malnutrition screening tool (MST), and patient-generated subjective global assessment (PG-SGA) are the most common screening tools, and each one possesses some benefits when screening patients for malnutrition; however, weight loss over a specific time period, dietary intake and anorexia must also be considered. The body mass index-adjusted weight loss grading system predicts survival. We recommend the application of MST or NRS, followed by PG-SGA, food intake determination, measurement of body weight, and its changes as well as body composition, biochemical nutritional markers, muscle function, and physical performance.

28 January 2021 in Critical Reviews in Food Science and Nutrition
Verified
Journal Article
Closed access
JLJulissa Luvián-Morales
Julissa Luvián-Morales
FVFrancisco Omar Varela-Castillo
Francisco Omar Varela-Castillo
LFLaura Flores-Cisneros
Laura Flores-Cisneros
LCLucely del Carmen Cetina-Pérez
Lucely del Carmen Cetina-Pérez
DCDenisse Castro-Eguiluz
Denisse Castro-Eguiluz
Chronic diseases are responsible for approximately 71% global deaths. These are characterized by chronic low-grade inflammation and metabolic alterations. “Functional foods” have been attributed with anti-inflammatory properties, demonstrated in cell lines and murine models; however, studies in humans are inconclusive. The purpose of this systematic review is to identify clinical trials that analyzed changes in inflammatory and metabolic mediators, in response to consumption of specific functional foods. A total of 3581 trials were screened and 88 were included for this review. Foods identified to regulate inflammation included cranberries, grapes, pomegranate, strawberries, wheat, whole grain products, low fat dairy products, yogurt, green tea, cardamom, turmeric, soy foods, almonds, chia seeds, flaxseed, pistachios, algae oil, flaxseed oil and grape seed oil. Clinical trials that focus on a dietary pattern rich in functional foods are necessary to explore if the additive effect of these foods lead to more clinically relevant outcomes.

1 June 2012 in Microbial Pathogenesis
Verified
Journal Article
Closed access
Roberto Rosales-ReyesRoberto Rosales-Reyes
Roberto Rosales-Reyes
APAraceli Pérez-López
Araceli Pérez-López
CSConcepción Sánchez-Gómez
Concepción Sánchez-Gómez
RHRosaura Ruth Hernández-Mote
Rosaura Ruth Hernández-Mote
DCDenisse Castro-Eguiluz
Denisse Castro-Eguiluz
CACelia Mercedes Alpuche-Aranda
Celia Mercedes Alpuche-Aranda

1 April 2019 in Journal of Human Nutrition and Dietetics
Verified
Journal Article
Closed access
PDF file
MSM. Sánchez
M. Sánchez
DCDenisse Castro-Eguiluz
Denisse Castro-Eguiluz
JLJ. Luvián‐Morales
J. Luvián‐Morales
RJR. Jiménez‐Lima
R. Jiménez‐Lima
JAJ. L. Aguilar‐Ponce
J. L. Aguilar‐Ponce
LCLucely del Carmen Cetina-Pérez
Lucely del Carmen Cetina-Pérez

1 July 2005 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
Roberto Rosales-ReyesRoberto Rosales-Reyes
Roberto Rosales-Reyes
CACelia Alpuche-Aranda
Celia Alpuche-Aranda
MRMaría de la Luz Ramírez-Aguilar
María de la Luz Ramírez-Aguilar
DCDenisse Castro-Eguiluz
Denisse Castro-Eguiluz
Vianney Ortiz-NavarreteVianney Ortiz-Navarrete
Vianney Ortiz-Navarrete
Gamma interferon (IFN-γ)-activated macrophages use an alternative processing mechanism to presentSalmonellaantigens to CD8+T lymphocytes. This pathway involves processing of antigen in a vacuolar compartment followed by secretion and loading of antigenic peptides to major histocompatibility complex class I (MHC-I) molecules on macrophage cell surface and bystander cells. In this study, we have shown that B lymphocytes are not able to processSalmonellaantigens using this alternative pathway. This is due to differences inSalmonella entericaserovar Typhimurium-containing vacuoles (SCV) when comparing late endosomal-lysosomal processing compartments in B lymphocytes to those in macrophages. The IFN-γ-activated IC21 macrophage cell line and A-20 B-cell line were infected with live or deadSalmonella entericaserovar Typhimurium. The SCV in B cells were in a late endosomal-lysosomal compartment, whereas SCV in macrophages were remodeled to a noncharacteristic late endosomal-lysosomal compartment over time. Despite the difference in SCV within macrophages and B lymphocytes,S. entericaserovar Typhimurium survives more efficiently within the IFN-γ-activated B cells than in activated macrophage cell lines. Similar results were found during in vivo acute infection. We determined that a lack of remodeling of late endosomal-lysosomal compartments by liveSalmonellainfection in B lymphocytes is associated with the inability to use the alternative MHC-I antigen-processing pathway, providing a survival advantage to the bacterium. Our data also suggest that the B lymphocyte late endosome-lysosome environment allows the expression ofSalmonellavirulence mechanisms favoring B lymphocytes in addition to macrophages and dendritic cells as a reservoir during in vivo infection.

1 July 2009 in Microbial Pathogenesis
Verified
Journal Article
Closed access
DCDenisse Castro-Eguiluz
Denisse Castro-Eguiluz
RPRosana Pelayo
Rosana Pelayo
VRVictor Rosales-Garcia
Victor Rosales-Garcia
Roberto Rosales-ReyesRoberto Rosales-Reyes
Roberto Rosales-Reyes
CACelia Alpuche-Aranda
Celia Alpuche-Aranda
Vianney Ortiz-NavarreteVianney Ortiz-Navarrete
Vianney Ortiz-Navarrete